Leukocyte Adhesion Deficiency (LAD) is a rare condition where white blood cells, especially neutrophils, have trouble moving to areas in the body where there is an infection. This happens because of a problem with a special molecule that helps the cells stick to blood vessel walls and travel to the infection site.
As a result, people with LAD often get frequent and serious infections. LAD is a genetic disorder passed down from both parents (an autosomal recessive condition), meaning a person is born with it due to changes in their DNA. Furthermore, this disorder manifests in 3 different types, which give rise to unique symptoms, diagnostic methods, and treatment procedures.
Keep reading for detailed insight!
The symptoms of LAD depend on its type:
LAD is a rare genetic disorder. It happens when certain genes don’t work properly, affecting how white blood cells fight infections.
It is caused by a mutation in the ITGB2 gene, which helps make a protein needed for white blood cells to stick to blood vessels and fight infection.
It is caused by a mutation in the SLC35C1 gene, which helps white blood cells move properly and recognize infection sites.
It is caused by a mutation in the gene for a protein called Kindlin 3, which is needed to turn on proteins (called integrins) that help white blood cells and platelets stick to blood vessels. In some cases, another gene called CalDAG-GEF1 may also be mutated.
LAD is passed down in an autosomal recessive pattern. This means a child must get one faulty gene from each parent to have the disease. If both parents are carriers, there is:
LAD is typically diagnosed through a combination of the following clinical and laboratory methods:
Doctors begin by checking symptoms, medical history, and the pattern of infections. LAD may be suspected in infants with repeated infections, especially if there’s no pus at the infection sites and very high white blood cell counts.
A complete blood count (CBC) is commonly used. It often shows high levels of neutrophils (a type of white blood cell). This condition is called neutrophilia and is a key sign of LAD.
LAD I, II, and III can be confirmed through molecular genetic testing. This test checks for mutations in specific genes:
A sample of the placenta is taken through a test called chorionic villus sampling (CVS). This helps check if the fetus has the same genetic mutation. LAD II can also be detected before birth by checking for the Bombay (hh) blood type. This test is done around 20 weeks of pregnancy.
Treatment options for LAD include:
It is an essential part of treatment for all types of LAD. Preventive antibiotics may be given to people with more severe forms, especially in LAD I.
Helpful for families to understand the condition and assess the risk in future pregnancies.
In moderate to severe cases, Ustekinumab is used, is not standard for LAD-I. Stem cell transplant (HSCT) is curative for severe cases. This helps control the chronic inflammation caused by the disease. In rare, life-threatening infections, granulocyte transfusions may be done.
Individuals usually respond well to regular antibiotics and careful monitoring.
People with serious bleeding problems may need blood transfusions to manage severe bleeding episodes. Infections are treated similarly to LAD I.
Includes wound care, dental care (especially for periodontitis), and regular monitoring for infections.
Although Leukocyte Adhesion Deficiency is a genetic condition, early diagnosis is key to better outcomes. Regular medical follow-ups and supportive therapies play an important role in managing the condition in the long term. With the right support and medical guidance, those affected by LAD can lead fulfilling lives.